CSafe, founded in 1979, is a well-established player in the Pharmaceutical industry, headquartered in the United States. They have a strong focus on delivering high-quality, temperature-controlled logistics solutions, ensuring life-enhancing products reach patients worldwide. With their slogan highlighting their comprehensive offerings, CSafe emphasizes their commitment to active and passive bulk air cargo, parcel shipping, and advanced digital solutions.
The company last received a Private Equity Round investment on 01 October 2016, backed by prominent investors Altaris Capital Partners and THL Partners. This reflects strong investor confidence in their patient-first approach and innovative capabilities. CSafe's longevity in the market underscores their expertise and adaptability, making them a noteworthy consideration for potential investors seeking opportunities within the pharmaceutical logistics domain.